Singh C, Wadhera S, Yanamandra U, Karunakaran P, Jindal N, Rani Kumar S, et al. High-dose hydroxyurea with differentiating agents for treating ultra-high-risk acute promyelocytic leukemia in resource-challenged settings. AO [Internet]. 2022 Dec. 2 [cited 2026 Jun. 20];61(12):1512-4. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/23787